Suppr超能文献

泛素 E3 连接酶 RAUL 通过泛素化转录因子 IRF7 和 IRF3 负调控 I 型干扰素。

The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3.

机构信息

Viral Oncology Program, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, CRB1 3M09, Baltimore, MD 21231, USA.

出版信息

Immunity. 2010 Dec 14;33(6):863-77. doi: 10.1016/j.immuni.2010.11.027.

Abstract

In the course of combating infectious agents, type I interferon (IFN) needs a timely downregulation mechanism to avoid detrimental overreaction. Here we showed a mechanism for restraining type I IFN responses, which relied on a HECT domain ubiquitin (Ub) E3 ligase, RAUL. RAUL limited type I IFN production by directly catalyzing lysine 48-linked polyubiquitination of both interferon regulatory factor 7 (IRF7) and IRF3 followed by proteasome-dependent degradation. Suppression of RAUL by dominant-negative RAUL or siRNA augmented both basal and virus-induced production of type I IFN, which resulted in reduced viral replication. The Kaposi's sarcoma-associated herpes virus immediate-early lytic cycle trigger protein RTA recruited this mechanism to augment its countermeasures against the host antiviral response. These results unveil a previously unrecognized "brake mechanism" for type I IFN that maintains proper low amounts of type I IFN under physiological conditions and restrains its magnitude when the antiviral response intensifies.

摘要

在与传染性病原体的斗争中,I 型干扰素(IFN)需要一种及时的下调机制来避免有害的过度反应。在这里,我们展示了一种限制 I 型 IFN 反应的机制,该机制依赖于一种 HECT 结构域泛素(Ub)E3 连接酶 RAUL。RAUL 通过直接催化干扰素调节因子 7(IRF7)和 IRF3 的赖氨酸 48 位连接的多泛素化,随后通过蛋白酶体依赖性降解,限制 I 型 IFN 的产生。显性负性 RAUL 或 siRNA 抑制 RAUL 会增强 I 型 IFN 的基础和病毒诱导产生,从而导致病毒复制减少。卡波西肉瘤相关疱疹病毒立即早期裂解周期触发蛋白 RTA 募集了这种机制来增强其对抗宿主抗病毒反应的对策。这些结果揭示了一种以前未被识别的 I 型 IFN“制动机制”,该机制在生理条件下维持适当的低水平 I 型 IFN,并在抗病毒反应增强时限制其幅度。

相似文献

6
RNF149 modulates the type I IFN innate antiviral immune responses through degrading IRF3.
PLoS Pathog. 2025 Apr 17;21(4):e1013051. doi: 10.1371/journal.ppat.1013051. eCollection 2025 Apr.
8
FoxO1 negatively regulates cellular antiviral response by promoting degradation of IRF3.
J Biol Chem. 2013 May 3;288(18):12596-604. doi: 10.1074/jbc.M112.444794. Epub 2013 Mar 26.
10
RNF26 temporally regulates virus-triggered type I interferon induction by two distinct mechanisms.
PLoS Pathog. 2014 Sep 25;10(9):e1004358. doi: 10.1371/journal.ppat.1004358. eCollection 2014 Sep.

引用本文的文献

1
E3 ligase RAD18 targets phosphorylated IRF3 to terminate IFNB1 transcription.
Nat Immunol. 2025 Sep;26(9):1581-1595. doi: 10.1038/s41590-025-02256-x. Epub 2025 Aug 29.
2
UBE3C promotes pancreatic ductal adenocarcinoma progression by catalysing p53 ubiquitination.
Mol Biol Rep. 2025 Jun 24;52(1):633. doi: 10.1007/s11033-025-10751-5.
3
RNF149 modulates the type I IFN innate antiviral immune responses through degrading IRF3.
PLoS Pathog. 2025 Apr 17;21(4):e1013051. doi: 10.1371/journal.ppat.1013051. eCollection 2025 Apr.
5
Endogenous metabolite N-chlorotaurine attenuates antiviral responses by facilitating IRF3 oxidation.
Redox Biol. 2025 Mar;80:103492. doi: 10.1016/j.redox.2025.103492. Epub 2025 Jan 7.
6
DYRK4 upregulates antiviral innate immunity by promoting IRF3 activation.
EMBO Rep. 2025 Feb;26(3):690-719. doi: 10.1038/s44319-024-00352-x. Epub 2024 Dec 19.
8
The multiple roles of interferon regulatory factor family in health and disease.
Signal Transduct Target Ther. 2024 Oct 9;9(1):282. doi: 10.1038/s41392-024-01980-4.
9
DDI2 protease controls embryonic development and inflammation via TCF11/NRF1.
iScience. 2024 Sep 5;27(10):110893. doi: 10.1016/j.isci.2024.110893. eCollection 2024 Oct 18.
10
UBE3C restricts EV-A71 replication by ubiquitination-dependent degradation of 2C.
J Virol. 2024 Oct 22;98(10):e0133524. doi: 10.1128/jvi.01335-24. Epub 2024 Aug 30.

本文引用的文献

1
Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes.
Science. 2010 Feb 26;327(5969):1135-9. doi: 10.1126/science.1182364.
2
Breaking the chains: structure and function of the deubiquitinases.
Nat Rev Mol Cell Biol. 2009 Aug;10(8):550-63. doi: 10.1038/nrm2731.
5
The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response.
EMBO Rep. 2008 Sep;9(9):930-6. doi: 10.1038/embor.2008.136. Epub 2008 Jul 18.
6
Turning NF-kappaB and IRFs on and off in DC.
Trends Immunol. 2008 Jul;29(7):329-36. doi: 10.1016/j.it.2008.03.005. Epub 2008 Jun 3.
7
HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation.
Virology. 2008 Mar 30;373(1):85-97. doi: 10.1016/j.virol.2007.10.042. Epub 2007 Dec 20.
8
DUBA: a deubiquitinase that regulates type I interferon production.
Science. 2007 Dec 7;318(5856):1628-32. doi: 10.1126/science.1145918. Epub 2007 Nov 8.
9
Autoinhibition of the HECT-type ubiquitin ligase Smurf2 through its C2 domain.
Cell. 2007 Aug 24;130(4):651-62. doi: 10.1016/j.cell.2007.06.050.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验